Patents Represented by Attorney Jeffrey A. Wilson
  • Patent number: 7282119
    Abstract: A process and apparatus to enable the continuous isolation of an organometallic compound, such as trimethylindium from a liquid feedstock. The liquid feedstock is delivered to a distillation column having two heating zones to effect dissociation of the feed stock thereby liberating the organometallic compound, which is collected as a vapor from the top of the column.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: October 16, 2007
    Assignee: Sigma-Aldrich Co.
    Inventors: Rajesh Odedra, Megan Ravetz, Graham Williams, Phillip Reeve Jacobs
  • Patent number: 7276598
    Abstract: The present invention discloses novel phosphoramidite reagents for use in oligonucleotide synthesis. The present invention further discloses novel methods for the conversion of terminal hydroxyl groups of oligonucleotides into phosphate monoesters. By employing novel reagents, as also disclosed herein, the methods are fully compatible with standard procedures for solid phase oligonucleotide synthesis and do not require additional processing steps. The inventive reagents to phosphorylate terminal hydroxyl groups of oligonucleotides are superior to the prior art in that they for the first time combine the desired attributes of being a solid compound for facile handling, comprising two ?-eliminating protective groups removable as fast or faster than the standard cyanoethyl group, providing a DMT-group for easy monitoring of the coupling efficiency, and enabling a fast final deprotection of the phosphorylated oligonucleotide without any extra manipulation steps.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: October 2, 2007
    Assignee: Sigma-Aldrich Co.
    Inventors: Kurt Vagle, Michael Leuck, Andreas Wolter